Market Overview:
The global carotid shunts market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of stroke and other cerebrovascular diseases, rising geriatric population, and technological advancements in carotid shunts devices. Based on type, the global carotid shunts market is segmented into outlying carotid shunts and inlying carotid shunts. Outlying carotid shunts are further classified into external ventricular drainage (EVD) systems and intracranial pressure (ICP) monitoring systems. Inlying carotid shunts are further classified into stent retrievers and embolic protection devices (EPDs). The outlying Carotid Shunts segment is expected to account for the largest share of the global Carotid Shunts market during the forecast period owing to its high usage rates for EVD systems and ICP monitoring systems across hospitals worldwide.
Product Definition:
A carotid shunt is a surgical procedure in which an opening is created between the common carotid arteries, allowing blood to bypass the blocked portion of one or both of these vessels. This procedure can be used to improve blood flow to the brain in cases of severe blockage or as a last resort before surgery to remove a mass blocking one or both carotid arteries.
Outlying Carotid Shunts:
Outlying Carotid Shunts (OCCS) is a minimally invasive procedure used to treat the cause of carotid artery stenosis or occlusion. OCCS uses a laser or ultrasound device to open the artery and allow blood flow. The most common symptom of carotid artery stenosis/occlusion is severe headache which may lead to neck pain, arm pain, and vision loss in one or both eyes.
Inlying Carotid Shunts:
Inlying Carotid Shunts are the variants of carotid shunt that is used to treat or prevent stroke by altering the blood flow in the carotid artery. The primary function of these devices is to help increase blood flow in an alternative artery, which has fewer obstructions and lower cholesterol levels than the main artery. In addition, it also helps reduce blockage in other arteries that feed into the brain.
Application Insights:
Based on application, the global market has been segmented into hospital, clinic and other. The hospital segment dominated the overall market in terms of revenue in 2017. This is due to a large patient base with various cardiac diseases requiring carotid endarterectomy procedures for treatment. Furthermore, increasing number of hospitals offering these surgeries as an outpatient procedure is also contributing to its growth.
The clinic segment is expected to grow at a lucrative rate over the forecast period owing to growing awareness about early diagnosis and effective treatment options for various cardiac diseases such as stroke caused by atherosclerosis and Carotid Intima Media Thickness (CIMT). Moreover, it can be performed as an outpatient procedure without any incision or stitches which makes it more appealing than conventional open surgery techniques.
Regional Analysis:
North America dominated the global carotid shunts market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to increasing prevalence of CVDs, stroke and TIA, growing geriatric population, and rising awareness about early diagnosis & treatment options for these conditions.
Asia Pacific is anticipated to grow at a lucrative rate during the same period owing to improving healthcare infrastructure in emerging countries such as India & China along with government initiatives for creating awareness about CVDs prevention & management techniques Early diagnosis has shown significant results in reducing mortality rates from cardiovascular diseases (CVDs) among patients suffering from acute coronary syndrome (ACS).
Growth Factors:
- Increasing incidence of stroke: The number of people affected by stroke is increasing at an alarming rate. This is mainly due to the aging population and rising rates of obesity, diabetes, and hypertension. As a result, the demand for carotid shunts is also expected to increase in the coming years.
- Growing awareness about carotid shunts: There is a growing awareness among people about the benefits of using carotid shunts for treating strokes. This is likely to boost demand for these devices in the near future.
- Technological advancements: The manufacturers are constantly working on developing new and innovative technologies that can improve the performance of carotid shunts products. This will help them capture a larger share of this market in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Carotid Shunts Market Research Report
By Type
Outlying Carotid Shunts, Inlying Carotid Shunts
By Application
Hospital, Clinic, Other
By Companies
Edwards Lifesciences Corporation, BD, Cardinal Health, Integra LifeSciences, LeMaitre Vascular, Inc.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
146
Number of Tables & Figures
103
Customization Available
Yes, the report can be customized as per your need.
Global Carotid Shunts Market Report Segments:
The global Carotid Shunts market is segmented on the basis of:
Types
Outlying Carotid Shunts, Inlying Carotid Shunts
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Edwards Lifesciences Corporation
- BD
- Cardinal Health
- Integra LifeSciences
- LeMaitre Vascular, Inc.
Highlights of The Carotid Shunts Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Outlying Carotid Shunts
- Inlying Carotid Shunts
- By Application:
- Hospital
- Clinic
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Carotid Shunts Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A carotid shunt is a surgically created opening in the neck between the two carotid arteries that allows blood to bypass part of the brain. Carotid shunts are used when there is an obstruction or blockage in one or both of the carotids, which can cause a stroke.
Some of the major companies in the carotid shunts market are Edwards Lifesciences Corporation, BD, Cardinal Health, Integra LifeSciences, LeMaitre Vascular, Inc..
The carotid shunts market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Carotid Shunts Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Carotid Shunts Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Carotid Shunts Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Carotid Shunts Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Carotid Shunts Market Size & Forecast, 2020-2028
4.5.1 Carotid Shunts Market Size and Y-o-Y Growth
4.5.2 Carotid Shunts Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Outlying Carotid Shunts
5.2.2 Inlying Carotid Shunts
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Carotid Shunts Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Carotid Shunts Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Outlying Carotid Shunts
9.6.2 Inlying Carotid Shunts
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Outlying Carotid Shunts
10.6.2 Inlying Carotid Shunts
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Outlying Carotid Shunts
11.6.2 Inlying Carotid Shunts
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Outlying Carotid Shunts
12.6.2 Inlying Carotid Shunts
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Outlying Carotid Shunts
13.6.2 Inlying Carotid Shunts
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Carotid Shunts Market: Competitive Dashboard
14.2 Global Carotid Shunts Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Edwards Lifesciences Corporation
14.3.2 BD
14.3.3 Cardinal Health
14.3.4 Integra LifeSciences
14.3.5 LeMaitre Vascular, Inc.
